FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based ...

The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

The Food and Drug Administration has introduced a new AI tool that could expedite the review and approval process for medical ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

The FDA rolled out its agency-wide AI tool weeks ahead of schedule, on Monday offering a look at the technology and how it ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.